3 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
Follow DCIS: new trials by email Literature Review of DCIS trials Research Report on DCIS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT 0.075 mg/kg - Breast Cancer, DCIS | Phase 1 / Phase 2 | Completed | Integro Theranostics | 22 | 2023-07-14 | 2026-05-20 |
| Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Chloroquine Standard Dose (500mg/week), Chloroquine Low Dose (250mg/week), Breast Biopsy - Carcinoma, Intraductal, Noninfiltrating, DCIS | Phase 1 / Phase 2 | Completed | Inova Health Care Services | 12 | 2009-12-01 | 2021-06-29 |
| DC Vaccine for Patients With Ductal Carcinoma In Situ HER-2 Pulsed Dendritic cell Vaccine - Breast Cancer, DCIS | Phase 1 / Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 58 | 2009-07-01 | 2020-04-10 |
Breast Neoplasms (3) · Carcinoma, Intraductal, Noninfiltrating (3) · Carcinoma, Ductal, Breast (1)
Adenocarcinoma (3) · Breast Carcinoma In Situ (3) · Breast Diseases (3) · Carcinoma (3) · Carcinoma in Situ (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Ductal, Lobular, and Medullary (3) · Neoplasms, Glandular and Epithelial (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Carcinoma, Ductal (1)
Biopsy (1) · Chloroquine (1)
Abramson Cancer Center at Penn Medicine (1) · Inova Health Care Services (1) · Integro Theranostics (1)
United States (3)
Brian J Czerniecki, M.D., Ph.D. (1) · Dan Thompson (1) · Kirsten H Edmiston, MD, FACS (1) · Priscilla McAuliffe, MD, PhD (1)